Page 100 - 202007
P. 100
variants in adult non-Hodgkin’s lymphoma patients:asso- Gene polymorphisms in folate metabolizing enzymes in
ciation with toxicity and survival[J]. Haematologica, adult acute lymphoblastic leukemia:effects on methotrex-
2007,92(4):478-485. ate-related toxicity and survival[J]. Haematologica,2009,
[20] HAASE R,ELSNER K,MERKEL N,et al. High dose 94(10):1391-1398.
methotrexate treatment in childhood ALL:pilot study on [31] PAKAKASAMA S,KANCHANAKAMHAENG K,KA-
the impact of the MTHFR 677C>T and 1298A>C poly- JANACHUMPOL S,et al. Genetic polymorphisms of fo-
morphisms on MTX-related toxicity[J]. Klinische Padiat- late metabolic enzymes and toxicities of high dose metho-
rie,2012,224(3):156-159. trexate in children with acute lymphoblastic leukemia[J].
[21] KARATHANASIS NV,STIAKAKI E,GOULIELMOS Ann Hematol,2007,86(8):609-611.
GN,et al. The role of the methylenetetrahydrofolate reduc- [32] SHIMASAKI N,MORI T,SAMEJIMA H,et al. Effects
tase 677 and 1298 polymorphisms in Cretan children with of methylenetetrahydrofolate reductase and reduced folate
acute lymphoblastic leukemia[J]. Genetic Testing and Mo- carrier 1 polymorphisms on high-dose methotrexate-in-
lecular Biomarkers,2011,15(1/2):5-10. duced toxicities in children with acute lymphoblastic leu-
[22] KOTNIK BF,GRABNAR I,GRABAR PB,et al. Associa- kemia or lymphoma[J]. Int J Pediatr Hematol Oncol,
tion of genetic polymorphism in the folate metabolic path- 2006,28(2):64-68.
way with methotrexate pharmacokinetics and toxicity in [33] SUTHANDIRAM S,GAN GG,ZAIN SM,et al. Effect of
childhood acute lymphoblastic leukaemia and malignant polymorphisms within methotrexate pathway genes on
lymphoma[J]. Eur J Clin Pharmacol,2011,67(10):993- methotrexate toxicity and plasma levels in adults with he-
1006. matological malignancies[J]. Pharmacogenomics,2014,
[23] 李天媛,王斌,徐康康,等.急性淋巴细胞白血病患儿亚甲 15(11):1479-1494.
基四氢叶酸还原酶基因 C677T 多态性与甲氨蝶呤毒副 [34] TANTAWY AA,EL-BOSTANY EA,ADLY AA,et al.
反应的研究[J].南京医科大学学报(自然科学版),2010, Methylene tetrahydrofolate reductase gene polymorphism
30(3):386-389. in Egyptian children with acute lymphoblastic leukemia
[24] 李静,王捷,赵军,等.亚甲基四氢叶酸还原酶基因多态性 [J]. Blood Coagul Fibrinol,2010,21(1):28-34.
与甲氨蝶呤不良反应的相关性[J].中国临床药理学杂 [35] 伍艳鹏,贺湘玲,邹润英,等.急性淋巴细胞白血病患儿
志,2014,30(12):1086-1088. MTHFR基因多态性与大剂量甲氨蝶呤化疗后不良反应
[25] 李静,王捷,郁长治,等.亚甲基四氢叶酸还原酶基因多态 的关系[J].广东医学,2015,36(3):413-416.
性与急性淋巴细胞白血病患者甲氨蝶呤化疗药物不良 [36] 郑苗苗,岳丽杰,陈小文,等.急性淋巴细胞白血病患儿
反应的相关性研究[J].中国临床药理学杂志,2017,33 MTHFR基因多态性与大剂量甲氨蝶呤毒副反应的关系
(17):1634-1636. [J].中国当代儿科杂志,2013,15(3):201-206.
[26] 廖清船,李晓蕾,刘思婷,等. MTHFR基因多态性及单体 [37] 焦力,周道斌,王书杰,等.血药浓度监测在大剂量甲氨蝶
型与大剂量甲氨蝶呤化疗毒性反应的相关性研究[J].中 呤治疗中的应用价值[J].中国医学科学院学报,2009,31
华流行病学杂志,2012,33(7):735-739. (5):564-566.
[27] 刘晶霞,陈洁平,谭文,等.亚甲基四氢叶酸还原酶基因多 [38] KODIDELA S,SURESH CP,DUBASHI B. Pharmacoge-
态性与急性淋巴细胞白血病患者甲氨蝶呤化疗毒副反 netics of methotrexate in acute lymphoblastic leukaemia:
应的研究[J].中国实验血液学杂志,2008,16(3):488- why still at the bench level?[J]. Eur J Clin Pharmacol,
492. 2014,70(3):253-260.
[28] LIU SG,LI ZG,CUI L,et al. Effects of methylenetetrahy- [39] YAO P,HE X,ZHANG R,et al. The influence of MTH-
drofolate reductase gene polymorphisms on toxicities dur- FR genetic polymorphisms on adverse reactions after
ing consolidation therapy in pediatric acute lymphoblastic methotrexate in patients with hematological malignancies:
leukemia in a Chinese population[J]. Leuk Lymphoma, a meta-analysis[J]. Hematology,2018,24(1):10-19.
2011,52(6):1030-1040. [40] 黄琳,于芝颖,顾群,等.亚甲基四氢叶酸还原酶基因多态
[29] 聂朝霞,刘岚,崔巍. MTHRF 基因 C677T 多态性与 ALL 性与甲氨蝶呤不良反应关系的Meta分析[J].中国临床药
患儿 MTX 血药浓度和毒副反应的相关性[J].医学临床 理学杂志,2016,32(2):183-185.
研究,2012,29(2):295-298. (收稿日期:2019-10-21 修回日期:2019-12-21)
[30] ONGARO A,DE MATTEI M,DELLA PORTA MG,et al. (编辑:刘明伟)
·858 · China Pharmacy 2020 Vol. 31 No. 7 中国药房 2020年第31卷第7期